A 58-year-old woman with stage IIIC ovarian cancer (FIGO 2014) undergoes primary cytoreductive surgery followed by neoadjuvant chemotherapy with paclitaxel and carboplatin. After 3 cycles, imaging shows residual disease of 1.2 cm. She completes 6 cycles total. Which of the following represents the strongest prognostic factor for her overall survival in this scenario?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.